Forvis Mazars Wealth Advisors’s Incyte INCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.35M Sell
47,176
-197
-0.4% -$19.5K 0.09% 91
2026
Q1
$4.46M Sell
47,373
-566
-1% -$56.5K 0.08% 100
2025
Q4
$4.73M Buy
47,939
+3,732
+8% +$361K 0.09% 100
2025
Q3
$3.75M Buy
44,207
+839
+2% +$66.3K 0.07% 109
2025
Q2
$2.95M Sell
43,368
-1,271
-3% -$80.5K 0.06% 124
2025
Q1
$2.7M Sell
44,639
-1,364
-3% -$95.1K 0.06% 129
2024
Q4
$3.18M Buy
46,003
+3,453
+8% +$246K 0.07% 123
2024
Q3
$2.81M Buy
42,550
+2,714
+7% +$173K 0.06% 142
2024
Q2
$2.41M Buy
39,836
+13,596
+52% +$770K 0.06% 142
2024
Q1
$1.49M Buy
+26,240
New +$1.58M 0.04% 185

Other funds holding INCY

Forvis Mazars Wealth Advisors's INCY Position: Q2 2026 in Review

Forvis Mazars Wealth Advisors reduced its Incyte (INCY) stake by 0.42% in Q2 2026, selling an estimated $19.5K and leaving 47,176 shares worth $5.35M. The position accounts for 0.09% of the portfolio, ranked #91.

Forvis Mazars Wealth Advisors first reported a position in INCY in Q1 2024 and has held it in 10 quarters since. 858 funds tracked by Wall St. Rank hold INCY as of Q2 2026.

  • Forvis Mazars Wealth Advisors held 47,176 shares of Incyte worth $5.35M as of Q2 2026.
  • Forvis Mazars Wealth Advisors sold 197 Incyte shares in Q2 2026, an estimated $19.5K.
  • Incyte made up 0.09% of Forvis Mazars Wealth Advisors's portfolio in Q2 2026, its #91 holding.
  • Forvis Mazars Wealth Advisors first reported a position in Incyte in Q1 2024 and has held it in 10 quarters since.
  • 858 funds tracked by Wall St. Rank held Incyte as of Q2 2026.

Based on Forvis Mazars Wealth Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.